Acasti Pharma Inc. (CVE:ACST – Get Free Report) shot up 1.8% on Wednesday . The stock traded as high as C$0.58 and last traded at C$0.58. 2,450 shares changed hands during trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Trading Up 1.8 %
The company has a current ratio of 9.74, a quick ratio of 9.41 and a debt-to-equity ratio of 0.52. The stock has a market capitalization of C$25.87 million, a price-to-earnings ratio of -1.07 and a beta of 1.22. The business has a 50 day simple moving average of C$0.58 and a 200-day simple moving average of C$0.58.
About Acasti Pharma
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
See Also
- Five stocks we like better than Acasti Pharma
- The How and Why of Investing in Gold Stocks
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- Trading Halts Explained
- 3 Penny Stocks Ready to Break Out in 2025
- What is a SEC Filing?
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
